000 | 01990 a2200529 4500 | ||
---|---|---|---|
005 | 20250514163942.0 | ||
264 | 0 | _c20040213 | |
008 | 200402s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.2003.04.150 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeldman, Andrew L | |
245 | 0 | 0 |
_aAnalysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cDec 2003 |
||
300 |
_a4560-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aChemotherapy, Cancer, Regional Perfusion |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLibutti, Steven K | |
700 | 1 | _aPingpank, James F | |
700 | 1 | _aBartlett, David L | |
700 | 1 | _aBeresnev, Tatiana H | |
700 | 1 | _aMavroukakis, Sharon M | |
700 | 1 | _aSteinberg, Seth M | |
700 | 1 | _aLiewehr, David J | |
700 | 1 | _aKleiner, David E | |
700 | 1 | _aAlexander, H Richard | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 21 _gno. 24 _gp. 4560-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2003.04.150 _zAvailable from publisher's website |
999 |
_c14405652 _d14405652 |